Dihydromyricetin

DRUG2 trials

Sponsors

University of Guadalajara, University of Southern California

Conditions

Alcohol-Related DisordersType 2 Diabetes Mellitus

Phase 1

Phase I, Dose-Escalation Study of Dihydromyricetin (DHM) to Treat Alcohol-Associated Liver Disease

Not yet recruitingNCT05623501

University of Southern CaliforniaAlcohol-Related Disorders

Start: 2024-09-15End: 2025-12-31Target: 12Updated: 2024-09-03

Phase 2

Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus

University of GuadalajaraType 2 Diabetes Mellitus

Start: 2019-10-30End: 2023-12-30Target: 24Updated: 2023-05-23